Kevin C. De Braganca, MD

Kevin C. De Braganca, MD

I am a pediatric neurologist who treats children and young adults with primary pediatric brain tumors such as medulloblastoma, ependymoma, and high- and low-grade gliomas (astrocytomas). I also treat patients with neurologic symptoms such as headaches, seizures, and neuropathic pain or weakness due to any cancer and/or cancer therapy.

I direct clinical trials at Memorial Sloan Kettering that are helping to advance the treatment of brain tumors. My particular area of interest is young adult patients with medulloblastoma or ependymoma. These tumors are rarely seen in this population, and therefore experience managing them is limited. At our Center, we have a base of experience to draw from and are working on the optimal treatment for patients with these rare cancers. Part of my professional responsibilities is also to mentor and teach our fellows, residents, and medical students to help further the care of patients with brain tumors.

Here at Memorial Sloan Kettering, we work as a team to provide patients and their families with coordinated care and support. This multifaceted approach to treating patients with brain tumors is what drew me to this field. The relationships that I develop with my patients and their families continue to fuel my motivation.

Location
Appointments for New Patients
866-886-9807
Phone
212-639-3449
Clinical Expertise

Pediatric Neuro-Oncology; Pediatric Neurology

Languages Spoken
English
Education

MD, University of Medicine and Dentistry of New Jersey/New Jersey Medical School

Residencies

NewYork-Presbyterian Hospital/Columbia University Medical Center

Fellowships

Children’s National Medical Center; Memorial Sloan Kettering Cancer Center

Board Certifications

Pediatrics; Neurology, with special certification in Child Neurology

Publications by Kevin C. De Braganca
Visit PubMed for full listing of Kevin C. De Braganca journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.